HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies BioTech April 17, 2023 HanchorBio Received IND Clearance of HCB101 Multi-regional Clinical Trial By US FDA HanchorBio Inc., a global clinical-stage biotechnology company developing…
